These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38213287)

  • 41. Evidence that trypanothione reductase is an essential enzyme in Leishmania by targeted replacement of the tryA gene locus.
    Tovar J; Wilkinson S; Mottram JC; Fairlamb AH
    Mol Microbiol; 1998 Jul; 29(2):653-60. PubMed ID: 9720880
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach.
    Pandey RK; Sharma D; Bhatt TK; Sundar S; Prajapati VK
    J Biomol Struct Dyn; 2015; 33(12):2541-53. PubMed ID: 26305585
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pseudoirreversible slow-binding inhibition of trypanothione reductase by a protein-protein interaction disruptor.
    de Lucio H; Toro MA; Camarasa MJ; Velázquez S; Gago F; Jiménez-Ruiz A
    Br J Pharmacol; 2020 Nov; 177(22):5163-5176. PubMed ID: 32888319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of selected antitumor agents as subversive substrate and potential inhibitor of trypanothione reductase: an alternative approach for chemotherapy of Leishmaniasis.
    Shukla AK; Patra S; Dubey VK
    Mol Cell Biochem; 2011 Jun; 352(1-2):261-70. PubMed ID: 21359528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of
    Madia VN; Ialongo D; Patacchini E; Exertier C; Antonelli L; Colotti G; Messore A; Tudino V; Saccoliti F; Scipione L; Ilari A; Costi R; Di Santo R
    Molecules; 2023 Jan; 28(1):. PubMed ID: 36615531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages.
    Dumas C; Ouellette M; Tovar J; Cunningham ML; Fairlamb AH; Tamar S; Olivier M; Papadopoulou B
    EMBO J; 1997 May; 16(10):2590-8. PubMed ID: 9184206
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of potential drugs against leishmaniasis targeting catalytic subunit of
    Bhowmik D; Jagadeesan R; Rai P; Nandi R; Gugan K; Kumar D
    J Biomol Struct Dyn; 2021 Mar; 39(5):1838-1852. PubMed ID: 32141397
    [No Abstract]   [Full Text] [Related]  

  • 48. Pyrrolopyrimidine vs Imidazole-Phenyl-Thiazole Scaffolds in Nonpeptidic Dimerization Inhibitors of Leishmania infantum Trypanothione Reductase.
    Revuelto A; Ruiz-Santaquiteria M; de Lucio H; Gamo A; Carriles AA; Gutiérrez KJ; Sánchez-Murcia PA; Hermoso JA; Gago F; Camarasa MJ; Jiménez-Ruiz A; Velázquez S
    ACS Infect Dis; 2019 Jun; 5(6):873-891. PubMed ID: 30983322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Probing the Interactions Responsible for the Structural Stability of Trypanothione Reductase Through Computer Simulation and Biophysical Characterization.
    Kumar A; Nimsarkar P; Singh S
    Protein J; 2022 Apr; 41(2):230-244. PubMed ID: 35364760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanistic and biological characterisation of novel
    Medeiros A; Benítez D; Korn RS; Ferreira VC; Barrera E; Carrión F; Pritsch O; Pantano S; Kunick C; de Oliveira CI; Orban OCF; Comini MA
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1345-1358. PubMed ID: 32588679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trypanothione reductase from Leishmania infantum: cloning, expression, purification, crystallization and preliminary X-ray data analysis.
    Baiocco P; Franceschini S; Ilari A; Colotti G
    Protein Pept Lett; 2009; 16(2):196-200. PubMed ID: 19200044
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of novel Leishmania major trypanothione synthetase inhibitors by high-throughput screening.
    Phan TN; Park KP; Benítez D; Comini MA; Shum D; No JH
    Biochem Biophys Res Commun; 2022 Dec; 637():308-313. PubMed ID: 36413853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase.
    Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK
    J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of plumbagin and its derivative as potential modulators of redox thiol metabolism of Leishmania parasite.
    Sharma N; Shukla AK; Das M; Dubey VK
    Parasitol Res; 2012 Jan; 110(1):341-8. PubMed ID: 21717278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glucose-6-phosphate dehydrogenase and Trypanothione reductase interaction protects Leishmania donovani from metalloid mediated oxidative stress.
    Ghosh AK; Saini S; Das S; Mandal A; Sardar AH; Ansari MY; Abhishek K; Kumar A; Singh R; Verma S; Equbal A; Ali V; Das P
    Free Radic Biol Med; 2017 May; 106():10-23. PubMed ID: 28179112
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LmABCB3, an atypical mitochondrial ABC transporter essential for Leishmania major virulence, acts in heme and cytosolic iron/sulfur clusters biogenesis.
    Martínez-García M; Campos-Salinas J; Cabello-Donayre M; Pineda-Molina E; Gálvez FJ; Orrego LM; Sánchez-Cañete MP; Malagarie-Cazenave S; Koeller DM; Pérez-Victoria JM
    Parasit Vectors; 2016 Jan; 9():7. PubMed ID: 26728034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of a novel virtual screening cascade protocol to identify potential trypanothione reductase inhibitors.
    Perez-Pineiro R; Burgos A; Jones DC; Andrew LC; Rodriguez H; Suarez M; Fairlamb AH; Wishart DS
    J Med Chem; 2009 Mar; 52(6):1670-80. PubMed ID: 19296695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled α-helical peptides with improved proteolytic stability.
    Ruiz-Santaquiteria M; de Castro S; Toro MA; de Lucio H; Gutiérrez KJ; Sánchez-Murcia PA; Jiménez MÁ; Gago F; Jiménez-Ruiz A; Camarasa MJ; Velázquez S
    Eur J Med Chem; 2018 Apr; 149():238-247. PubMed ID: 29501944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A fast virtual screening approach to identify structurally diverse inhibitors of trypanothione reductase.
    Maccari G; Jaeger T; Moraca F; Biava M; Flohé L; Botta M
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5255-8. PubMed ID: 21807515
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leishmania amazonensis trypanothione reductase: evaluation of the effect of glutathione analogs on parasite growth, infectivity and enzyme activity.
    Castro-Pinto DB; Lima EL; Cunha AS; Genestra M; De Léo RM; Monteiro F; Leon LL
    J Enzyme Inhib Med Chem; 2007 Feb; 22(1):71-5. PubMed ID: 17373550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.